Skip to main content
. 2009 Aug 27;9:300. doi: 10.1186/1471-2407-9-300

Figure 1.

Figure 1

Heterogeneity of chemosensitivity for (a) docetaxel (b) cisplatin, (c) cisplatin with docetaxel, (d) cisplatin with gemcitabine, and (e) docetaxel with gemcitabine, (f) gemcitabine. Each line represents a different tumor tested at six concentrations.